AstraZeneca cuts US workforce by 24%

AstraZeneca is reducing its sales force by cutting 1,150 jobs. These changes will account for roughly 24% of the company's sales organization in the US.

AstraZeneca is reducing its sales force by cutting 1,150 jobs. These changes will account for roughly 24% of the company's sales organization in the US. The impact of the cuts will vary by geography and selling teams, the company said in a statement.

Employees will have the option to self-identify to potentially leave the company. All decisions will be finalized by early February 2012.

AstraZeneca press officer Tony Jewell declined to discuss the communication strategies related to the layoffs with PRWeek.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.